Clinical Trial: A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07835074) titled 'A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years' on Sept. 15.

Brief Summary: The goal of this clinical trial is to learn whether DEP114 is effective in treating acute exacerbations of persistent allergic rhinitis in children aged 6 to less than 12 years. The study will also evaluate the safety of DEP114.

Participants will:

* Take DEP114 or desloratadine once daily for 5 days (up to a maximum of 7 days).

* Keep a diary of their symptoms.

Study Start Date: June, 2027

Study Type: INTERVENTIONAL

Condition: Persistent Allergic Rhinitis

Interv...